ISRN Hematology · 2013 · 41 citations · 19 references
MedicineGeneticsHematologyHuman GeneticsIron Metabolism DisordersMedical GeneticsAnemiaIron DeficiencyIron Deficiency DisordersRed Blood Cell DisordersSickle Cell DiseaseAnemia DiagnosisComplete Blood Count InterpretationHemoglobin LevelsHemoglobinopathy ScreeningIron Deficiency AssessmentIron Deficiency DiagnosisPopulation Screening For HemoglobinopathiesSickle Cell Anemia
Screening for β -thalassemia trait (BTT) relies on measuring hemoglobin (Hb) A2. Since multiple factors can affect HbA2 levels, the screening can become unreliable. In 1356 healthy Arabs enrolled into a federally funded premarital BTT screening program, the effects of iron deficiency (ID), α (+)-thalassemia trait, gender, smoking, and tribalism on HbA2 were studied. The complete blood count and hemoglobin fractions were determined on the entire cohort; serum ferritin (<15 μ g/L) in 391 subjects was used to determine ID. BTT was present in 29 (2.1%) subjects (HbA2 > 3.5%). Among 77(20.3%) subjects with ID, the mean HbA2 (2.30 ± 0.23%) was 0.2% lower than in subjects without iron deficiency (2.50 ± 0.24%, P < 0.0001). In 65 (38%)/172 subjects with phenotypic α (+)-thalassemia trait, the mean HbA2 (2.43 ± 0.24%) was 0.13% lower than in subjects without α (+)-thalassemia trait, P < 0.0001. The mean HbA2 did not differ between males and females, smokers and nonsmokers, and between the tribes. Thus, 35 (2.6%) subjects with HbA2 between 3.2 and 3.5% were at a risk of false negative diagnosis of BTT. Since iron deficiency and α (+)-thalassemia are both common and both lower HbA2, modifications in screening recommendations for BTT are proposed.
19
Genetic modifiers of beta-thalassemia.
Swee Lay Thein · PubMed · 2005 · 191 citations
Life Sciences, Genetics, Hematology +11
α-Thalassemia in the United Arab Emirates
S. El-Kalla, E. Baysal · Acta Haematologica · 1998 · 78 citations